Review ArticleClinical Review

Management of Acute Pulmonary Embolism With a Pulmonary Embolism Response Team

Jason R. Cuomo, Vishal Arora and Thad Wilkins
The Journal of the American Board of Family Medicine March 2021, 34 (2) 402-408; DOI: https://doi.org/10.3122/jabfm.2021.02.200308

References

  1. ↵
    Office of the Surgeon General (US); National Heart, Lung, and Blood Institute (US). The Surgeon General's Call to Action to Prevent Deep Vein Thrombosis and Pulmonary Embolism. Rockville (MD): Office of the Surgeon General (US); 2008. Available at: https://www.ncbi.nlm.nih.gov/books/NBK44178. Accessed March 26, 2021.
  2. ↵
    Centers for Disease Control and Prevention. Venous Thromboembolism in Adult Hospitalizations — United States, 2007–2009. MMWR 2012;61:401–23. Available at: https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6122a1.htm. Accessed March 26, 2021.
    OpenUrlPubMed
  3. ↵
    1. Braekkan SK,
    2. Grosse SD,
    3. Okoroh EM,
    4. et al
    . Venous thromboembolism and subsequent permanent work-related disability. J Thromb Haemost 2016;14:1978–87.
    OpenUrl
  4. ↵
    1. Piran S,
    2. Le Gal G,
    3. Wells PS,
    4. et al
    . Outpatient treatment of symptomatic pulmonary embolism: a systematic review and meta-analysis. Thromb Res 2013;132:515–9.
    OpenUrlCrossRefPubMed
  5. ↵
    1. Rivera-Lebron B,
    2. McDaniel M,
    3. Ahrar K
    , PERT Consortium, et al. Diagnosis, Treatment and Follow Up of Acute Pulmonary Embolism: Consensus Practice from the PERT Consortium. Clin Appl Thromb Hemost 2019;25:1076029619853037–16.
    OpenUrl
  6. ↵
    1. Kucher N,
    2. Boekstegers P,
    3. Müller OJ,
    4. et al
    . Randomized, controlled trial of ultrasound-assisted catheter-directed thrombolysis for acute intermediate-risk pulmonary embolism. Circulation 2014;129:479–86.
    OpenUrlAbstract/FREE Full Text
  7. ↵
    1. Piazza G,
    2. Hohlfelder B,
    3. Goldhaber S,
    4. Piazza G,
    5. Ohlfelder B,
    6. Jaff MR,
    7. et al
    . A prospective, single-arm, multicenter trial of ultrasound-facilitated, catheter-directed, low-dose fibrinolysis for acute massive and submassive pulmonary embolism: the SEATTLE II study. JACC Cardiovasc Interv 2015;8:1382–92.
    OpenUrlCrossRefPubMed
  8. ↵
    1. Todoran TM,
    2. Giri J,
    3. Barnes GD
    , PERT Consortium, et al. Treatment of submassive and massive pulmonary embolism: a clinical practice survey from the second annual meeting of the Pulmonary Embolism Response Team Consortium. J Thromb Thrombolysis 2018;46:39–49.
    OpenUrl
  9. ↵
    1. Kucher N,
    2. Rossi E,
    3. Rosa M,
    4. Goldhaber S
    . Massive pulmonary embolism. Circulation 2006;113:577–82.
    OpenUrlAbstract/FREE Full Text
  10. ↵
    1. Secemsky E,
    2. Chang Y,
    3. Jain CC,
    4. et al
    . Contemporary management and outcomes of patients with massive and submassive pulmonary embolism. Am J Med 2018;131:1506–14.e0.
    OpenUrlPubMed
  11. ↵
    1. Giri J,
    2. Sista A,
    3. Weinberg I,
    4. et al
    . Interventional therapies for acute pulmonary embolism: current status and principles for development of novel evidence: a scientific statement from the American Heart Association. Circulation 2019;140:e774–e801.
    OpenUrl
  12. ↵
    1. Jaff MR,
    2. McMurtry MS,
    3. Archer SL
    , American Heart Association Council on Arteriosclerosis, Thrombosis and Vascular Biology, et al. Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association [published correction appears in Circulation. 2012 Aug 14;126(7):e104] [published correction appears in. Circulation. 2012 Mar 20;125(11):e495]. Circulation 2011;123:1788–830.
    OpenUrlFREE Full Text
  13. ↵
    1. Kasper W,
    2. Konstantinides S,
    3. Geibel A,
    4. et al
    . Management strategies and determinants of outcome in acute major pulmonary embolism: results of a multicenter registry. J Am Coll Cardiol 1997;30:1165–71.
    OpenUrlFREE Full Text
  14. ↵
    1. Wan S,
    2. Quinlan DJ,
    3. Agnelli G,
    4. Eikelboom JW
    . Thrombolysis compared with heparin for the initial treatment of pulmonary embolism: a meta-analysis of the randomized controlled trials. Circulation 2004;110:744–9.
    OpenUrlAbstract/FREE Full Text
  15. ↵
    1. Chatterjee S,
    2. Chakraborty A,
    3. Weinberg I,
    4. et al
    . Thrombolysis for pulmonary embolism and risk of all-cause mortality, major bleeding, and intracranial hemorrhage: a meta-analysis. JAMA 2014;311:2414–21.
    OpenUrlCrossRefPubMedWeb of Science
  16. ↵
    1. Meyer G,
    2. Vicaut E,
    3. Danays T,
    4. et al
    . Fibrinolysis for patients with intermediate-risk pulmonary embolism. N Engl J Med 2014;370:1402–11.
    OpenUrlCrossRefPubMedWeb of Science
  17. ↵
    1. Konstantinides S,
    2. Vicaut E,
    3. Danays T,
    4. et al
    . Impact of thrombolytic therapy on the long-term outcome of intermediate-risk pulmonary embolism. J Am Coll Cardiol 2017;69:1536–44.
    OpenUrlFREE Full Text
  18. ↵
    1. Pengo V,
    2. Lensing AW,
    3. Prins MH
    , Thromboembolic Pulmonary Hypertension Study Group, et al. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med 2004;350:2257–64.
    OpenUrlCrossRefPubMedWeb of Science
  19. ↵
    1. Goldhaber SZ,
    2. Haire WD,
    3. Feldstein ML,
    4. et al
    . Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusion. Lancet 1993;341:507–11.
    OpenUrlCrossRefPubMedWeb of Science
  20. ↵
    1. Konstantinides S,
    2. Tiede N,
    3. Geibel A,
    4. Olschewski M,
    5. Just H,
    6. Kasper W
    . Comparison of alteplase versus heparin for resolution of major pulmonary embolism. Am J Cardiol 1998;82:966–70.
    OpenUrlCrossRefPubMedWeb of Science
  21. ↵
    1. Aujesky D,
    2. Roy PM,
    3. Verschuren F,
    4. et al
    . Outpatient versus inpatient treatment for patients with acute pulmonary embolism: an international, open-label, randomised, non-inferiority trial. Lancet 2011;378:41–8.
    OpenUrlCrossRefPubMedWeb of Science
  22. ↵
    1. Goldhaber SZ,
    2. Visani L,
    3. De Rosa M
    . Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet 1999;353:1386–9.
    OpenUrlCrossRefPubMedWeb of Science
  23. ↵
    1. Fiumara K,
    2. Kucher N,
    3. Fanikos J,
    4. Goldhaber SZ
    . Predictors of major hemorrhage following fibrinolysis for acute pulmonary embolism. Am J Cardiol 2006;97:127–9.
    OpenUrlCrossRefPubMedWeb of Science
  24. ↵
    1. Rosovsky R,
    2. Chang Y,
    3. Rosenfield K,
    4. et al
    . Changes in treatment and outcomes after creation of a pulmonary embolism response team (PERT), a 10-year analysis. J Thromb Thrombolysis 2019;47:31–40.
    OpenUrlCrossRefPubMed
  25. ↵
    1. Laporte S,
    2. Mismetti P,
    3. Décousus H
    , the RIETE Investigators, et al. Clinical predictors for fatal pulmonary embolism in 15,520 patients with venous thromboembolism: findings from the Registro Informatizado de la Enfermedad TromboEmbolica venosa (RIETE) Registry. Circulation 2008;117:1711–6.
    OpenUrlAbstract/FREE Full Text
  26. ↵
    1. Kang DK,
    2. Thilo C,
    3. Schoepf UJ,
    4. et al
    . CT signs of right ventricular dysfunction: prognostic role in acute pulmonary embolism. JACC Cardiovasc Imaging 2011;4:841–9.
    OpenUrlAbstract/FREE Full Text
  27. ↵
    1. Aujesky D,
    2. Obrosky DS,
    3. Stone RA,
    4. et al
    . Derivation and validation of a prognostic model for pulmonary embolism. Am J Respir Crit Care Med 2005;172:1041–6.
    OpenUrlCrossRefPubMedWeb of Science
  28. ↵
    1. Aujesky D,
    2. Roy PM,
    3. Le Manach CP,
    4. et al
    . Validation of a model to predict adverse outcomes in patients with pulmonary embolism. Eur Heart J 2006;27:476–81.
    OpenUrlCrossRefPubMedWeb of Science
  29. ↵
    1. Jiménez D,
    2. Aujesky D,
    3. Moores L
    , RIETE Investigators, et al. Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism. Arch Intern Med 2010;170:1383–9.
    OpenUrlCrossRefPubMedWeb of Science
  30. ↵
    1. Lankeit M,
    2. Jiménez D,
    3. Kostrubiec M,
    4. et al
    . Predictive value of the high-sensitivity troponin T assay and the simplified Pulmonary Embolism Severity Index in hemodynamically stable patients with acute pulmonary embolism: a prospective validation study. Circulation 2011;124:2716–24.
    OpenUrlAbstract/FREE Full Text
  31. ↵
    1. Kaeberich A,
    2. Seeber V,
    3. Jiménez D,
    4. et al
    . Age-adjusted high-sensitivity troponin T cut-off value for risk stratification of pulmonary embolism. Eur Respir J 2015;45:1323–31.
    OpenUrlAbstract/FREE Full Text
  32. ↵
    1. Lankeit M,
    2. Jiménez D,
    3. Kostrubiec M,
    4. et al
    . Validation of N-terminal pro-brain natriuretic peptide cut-off values for risk stratification of pulmonary embolism. Eur Respir J 2014;43:1669–77.
    OpenUrlAbstract/FREE Full Text
  33. ↵
    1. Kabrhel C,
    2. Rosovsky R,
    3. Channick R,
    4. et al
    . A multidisciplinary pulmonary embolism response team: initial 30-month experience with a novel approach to delivery of care to patients with submassive and massive pulmonary embolism. Chest 2016;150:384–93.
    OpenUrlCrossRefPubMed
  34. ↵
    1. Frémont B,
    2. Pacouret G,
    3. Jacobi D,
    4. Puglisi R,
    5. Charbonnier B,
    6. de Labriolle A
    . Prognostic value of echocardiographic right/left ventricular end-diastolic diameter ratio in patients with acute pulmonary embolism: results from a monocenter registry of 1,416 patients. Chest 2008;133:358–62.
    OpenUrlCrossRefPubMedWeb of Science
  35. ↵
    1. Lobo JL,
    2. Holley A,
    3. Tapson V
    , the PROTECT and the RIETE investigators, et al. Prognostic significance of tricuspid annular displacement in normotensive patients with acute symptomatic pulmonary embolism. J Thromb Haemost 2014;12:1020–7.
    OpenUrl
  36. ↵
    1. Pruszczyk P,
    2. Goliszek S,
    3. Lichodziejewska B,
    4. et al
    . Prognostic value of echocardiography in normotensive patients with acute pulmonary embolism. JACC Cardiovasc Imaging 2014;7:553–60.
    OpenUrlAbstract/FREE Full Text
  37. ↵
    1. Tu T,
    2. Toma C,
    3. Tapson VF,
    4. et al
    . A prospective, single-arm, multicenter trial of catheter-directed mechanical thrombectomy for intermediate-risk acute pulmonary embolism: the FLARE study. JACC Cardiovasc Interv 2019;12:859–69.
    OpenUrlAbstract/FREE Full Text
  38. ↵
    1. Konstantinides SV,
    2. Meyer G
    . The 2019 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J 2019;40:3453–5.
    OpenUrlPubMed
    1. Kearon C,
    2. Akl EA,
    3. Ornelas J,
    4. et al
    . Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report [published correction appears in. Chest. 2016 Oct;150(4):988]. Chest 2016;149:315–52.
    OpenUrlCrossRefPubMed
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools

Jump to section

Keywords